farmacología básica introducción. concepto, evolución histórica, subdivisión de la farmacología concepto la farmacología es aquella ciencia que trata de los. T.4 Farmacologia. Course: Farmacologia ().p2hv{}.p2hv. stopoverlappingourstyleplease{position:absolute;top:0;left:0;bottom:0;width: px;padding Antibacterianos/farmacologia Bandagens Biguanidas/farmacologia Infecção Hospitalar/prevenção & controle Antibacterianos/administração & dosagem.

Author: Grozil Goltirg
Country: Iceland
Language: English (Spanish)
Genre: Education
Published (Last): 4 June 2010
Pages: 409
PDF File Size: 6.88 Mb
ePub File Size: 10.66 Mb
ISBN: 671-6-55838-973-8
Downloads: 91724
Price: Free* [*Free Regsitration Required]
Uploader: Kazrale

To use this website, you must agree to our Privacy Policyincluding cookie policy. Efficacy of metformin in farmacologa with non-insulin-dependent diabetes mellitus. Summary of the second report of the NCEP expert panel on the detection, evaluation, and treatment of high blood cholesterol.

Slama et al, Lancetp Weight gain is the most notable side effect; allergy occurs rarely. Plasma lipid values are based on those recommended by the American Diabetes Association and the National Cholesterol Education Program.

Simultaneously while a PHMB soaked dressing carries out these actions, it creates an environment favorable to the proliferation of the normal flora found in the epidermis.

Effects of Obesity and Diabetes Following a glucose challenge after overnight fasting, plasma insulin biguznidas are dependent upon obesity as well as diabetes.

Thin individuals with or without altered glucose tolerance have normal basal insulin levels, while obese persons have elevated basal insulin levels regardless of glucose tolerance status. The main risk accompanying sulfonylurea treatment is the potential for prolonged hypoglycemia.

Free Pharmacology Flashcards about Farmacologia I

N Engl J Med. It is generally given one to three times daily; therapy is initiated at a low dose, which is gradually raised.

After a glucose challenge, both thin and obese individuals with type 2 diabetes demonstrate reduced early insulin responses when compared with their respective control groups. Rev Enferm ; 29 6: Basic Characteristics of Metformin Metformin, the sole available representative of the biguanide class in the United States, decreases hepatic glucose production.


Secretaria de Estado da Saúde – BVS

Plasma Glucose Cutoff Points The most recent criteria for the diagnosis of diabetes include new plasma glucose cutoff points. The main risk associated with the use of metformin is the potential for lactic acidosis, which is increased in patients with renal impairment or hepatic disease and cardiac or respiratory insufficiency. These agents are thus effective only if functioning pancreatic b-cells are present.

As opposed to porous gauze dressings, a PHMB dressing remains active during 72 hours even in wet environs. The sulfonylureas may be given once or twice daily, while repaglinide, the only agent in the meglitinides group available in the United States, is given three times daily.

Its wide anti-micro-bacterial range prevents infections in surgical, acute or chronic wounds and in any type of intra-corporal access susceptible to infection, such as by means of intravascular catheters, tracheotomies, or thoracic tubes. Medical Management of Type 2 Diabetes.

When an oral glucose tolerance test OGTT is performed, the 2-hour plasma glucose PG test is used to make the diagnosis. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects.

Mechanisms of Action The six classes of therapeutic agents used in the management of type 2 diabetes mellitus may be divided into three groups by their basic mechanism of action.

It reduces the plasma level of glycosylated hemoglobin HbA1c by 1. Registro Esqueceu sua senha?

Gestational diabetes mellitus is a fourth type in this new classification system. Standards of medical care for patients with diabetes mellitus. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. The highest prevalence rates During treatment with the insulin secretagogues, a reduction of glycosylated hemoglobin HbA1c by approximately 1.

Prevalence rates rose with age, with a plateau after age 75 years. Data from American Diabetes Association. To make this website work, we log user data and share it with processors. The cutoff points for the intermediate stage of hyperglycemia denoted by the terms impaired fasting glucose IFG and impaired glucose tolerance IGT have been adjusted to conform to the new diagnostic criteria for diabetes mellitus.


On the one hand, this PHMB soaked dressing inhibits bacterial growth in the areas where it is applied and, on the other hand, it prevents the penetration of microorganisms through the dressing itself. Insulin levels in the fasting state are dependent upon the degree of obesity. Type 2 diabetes includes those cases that result from insulin resistance accompanied by a defect in insulin secretion. Traditionally gauze dressings have been used to cover and protect farmacollogia although their porous structure does not constitute an efficient barrier against bacterial penetration, especially when a dressing becomes wet due to the effects of a wound oozing and draining.

Basic Characteristics of the Sulfonylureas and the Meglitinides The insulin secretagogues, which include the biguxnidas and the meglitinides, lower plasma glucose by augmenting insulin secretion by the pancreatic b-cells. Minor gastrointestinal side effects, such as diarrhea and nausea, may be alleviated by lowering the dose. American Diabetes Farmaco,ogia This agent works only in the presence of insulin, which may be of endogenous or exogenous origin. Farmacologka method may be used for the repeat test.

Recently the use of a dressing soaked in a 0. However, obese individuals with type 2 diabetes have higher post-glucose insulin levels than do thin individuals with normal glucose tolerance, thus demonstrating the persistence of the effect of obesity on insulin secretion.